Clinical Trial Update: Effects of Subanesthetic Concentrations of Nitrous Oxide - 1 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating subanesthetic concentrations of nitrous oxide for opioid use disorder and other substance-related disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Substance Use Disorder

Drugs mentioned

• Nitrous oxide (nitrous oxide)

Snippet

Sponsor: University of Chicago | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 2 | Status: COMPLETED